There’s long been a global shortage of the BCG vaccine for bladder cancer. But since ImmunityBio won FDA approval for Anktiva, an immunotherapy meant to be used along with the…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
